Securities code: 003020 securities abbreviation: Hefei Lifeon Pharmaceutical Co.Ltd(003020) Announcement No.: 2022-004 Hefei Lifeon Pharmaceutical Co.Ltd(003020)
Announcement on the resolution of the 17th meeting of the Fourth Board of directors
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Meetings of the board of directors
Hefei Lifeon Pharmaceutical Co.Ltd(003020) (hereinafter referred to as “the company”) notified all directors of the company by e-mail, telephone, SMS and other means at the 17th meeting of the Fourth Board of directors on January 19, 2022. The meeting was held on January 22, 2022 in the conference room on the fourth floor of the company by means of on-site combined with communication voting. There were 7 directors who should attend the meeting, and 7 directors actually attended the meeting, including 3 directors who attended the meeting by means of communication. Independent directors Mr. Liu Shoujin, Mr. Zhou Shihong and Mr. Yang Murong attended the meeting and voted by means of communication. Some supervisors and senior managers of the company attended the meeting as nonvoting delegates. The meeting was presided over by Mr. Ji Junqiu, chairman of the company.
The convening of this board meeting complies with the provisions of relevant laws, administrative regulations, departmental rules, normative documents and the articles of association.
2、 Deliberations of the board meeting
After careful deliberation and voting, the directors attending the meeting considered and adopted the following proposals:
1. Proposal on transferring part of the equity of Nanjing minoway Pharmaceutical Technology Co., Ltd
It is agreed that the company will transfer 4.9383% of the equity of Nanjing minoway Pharmaceutical Technology Co., Ltd. (corresponding to the registered capital of 80000 yuan) at the price of 32.0988 million yuan, and the transferee is Pingtan Wenzhou Ruiji investment partnership (limited partnership) (transfer the registered capital of 7626200 yuan, corresponding to 4.7075% equity) Pingtan fanrun enterprise management partnership (limited partnership) (transferred 373800 yuan of registered capital, corresponding to 0.2307% equity). Authorize Mr. Ji Junqiu, the chairman of the company, to negotiate specific matters of equity transfer with the trading party and sign the above equity transfer agreement and other relevant documents.
For details, please refer to securities times, Securities Daily, Shanghai Securities News, China Securities News and cninfo on the same day（ http://www.cn.info.com.cn. ）Announcement on the transfer of part of the equity of participating companies (Announcement No.: 2022-005) disclosed on the.
Voting: 7 in favor, 0 against and 0 abstention.
Outcome: adopted
3、 Document for future reference 1. Resolution of the 17th meeting of the Hefei Lifeon Pharmaceutical Co.Ltd(003020) Fourth Board of directors. It is hereby announced.
Hefei Lifeon Pharmaceutical Co.Ltd(003020) board of directors
January 25, 2022
